CN104147346B - It is a kind of to treat the anginal Chinese medicine compound prescription of coronary artery diffusivity lesion - Google Patents
It is a kind of to treat the anginal Chinese medicine compound prescription of coronary artery diffusivity lesion Download PDFInfo
- Publication number
- CN104147346B CN104147346B CN201410360492.5A CN201410360492A CN104147346B CN 104147346 B CN104147346 B CN 104147346B CN 201410360492 A CN201410360492 A CN 201410360492A CN 104147346 B CN104147346 B CN 104147346B
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- coronary artery
- blood
- coptis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention is a kind of to treat the anginal Chinese medicine compound prescription of coronary artery diffusivity lesion, the raw material including following component, by weight for:15~45g of Radix Astragali, 10~30g of Radix Ophiopogonis, 9~15g of Rhizoma Chuanxiong, 6~9g of leech, 15~30g of Radix Puerariae, 9~18g of Fructus Forsythiae, 9~15g of the coptis, 6~18g of cape jasmine, 6~12g of 9~27g of cassia twig, 9~27g of Radix Paeoniae Alba and Radix Glycyrrhizae;It can also further comprise any one or the combination of several of them in following raw materials according:6~15g of Schisandra chinensis, 6~15g of radix scutellariae, 12~30g of 10~30g of corydalis tuber, 2~6g of Radix Notoginseng powder and Radix Codonopsis.For treating coronary artery diffusivity lesion, can apparent patient's myocardial ischemia and angina pectoris symptom, solve the problems, such as clinical doctor trained in Western medicine at present to this disease cannot row coronary blood flow Reconstruction it is awkward, therapy is simple and easy to do, has no adverse reaction, curative for effect.
Description
Technical field
The invention belongs to the field of Chinese medicines, it is related to and a kind of treats the anginal Chinese medicine compound prescription of coronary artery diffusivity lesion.
Background technology
Coronary artery diffusivity lesion refer to coronary stenosis length be more than 20mm, be coronary artery pathological changes complicated type it
One, patient is present with angina pectoris and heart function declines, percutaneous coronary intervention(PCI)Operating difficulty is big, intraoperative compliaction hair
Raw rate is high, its postoperative restenosis rate is high while is also the independent hazard factor of PCI postoperative restenosis.Narrow remote end diffuses venereal disease
Become or diameter is meticulous can limit bypass operation of coronary artery(CABG)Grafting vessel and previous anastomotic distal end native blood vessel blood flow afterwards, cause
The generation of major adverse cardiovascular events, therefore, some coronary artery blood vessel diffusivity lesion patients for these reasons, can not be preced with into percutaneous
Shape arterial intervention(PCI)And coronary artery bypass grafting(CABG)Based on coronary artery revascularization.Studies have reported that:It is mostly height to diffuse patch
Endanger patient, and atherosclerosis is extensive, and calcification is apparent, and the death rate is high.Traditional Chinese medicine has in terms of angiocardiopathy is treated and can not replace
The effect in generation, Chinese medicine treatment coronary artery diffusivity lesion obtain many achievements in clinical studies.
The content of the invention
The purpose of the present invention:It is diffused mainly for the coronary artery that can not clinically carry out PCI or CABG coronary artery revascularizations
Venereal disease becomes patient, and by being inquired into its interpretation of the cause, onset and process of an illness, invention is a kind of to treat the anginal Chinese medicine compound prescription of coronary artery diffusivity lesion, and takes
The effect of good was obtained, a kind of new method is provided for the solution of the clinical problem.
Chinese medicine compound prescription technical solution of the present invention is:
It is a kind of to treat the anginal Chinese medicine compound prescription of coronary artery diffusivity lesion, the raw material including following component, by weight for:It is yellow
15~45g of stilbene, 10~30g of Radix Ophiopogonis, 9~15g of Rhizoma Chuanxiong, 6~9g of leech, 15~30g of Radix Puerariae, 9~18g of Fructus Forsythiae, the coptis 9~
15g, 6~18g of cape jasmine, 6~12g of 9~27g of cassia twig, 9~27g of Radix Paeoniae Alba and Radix Glycyrrhizae.
Wherein, preferably:Radix Astragali 45g, Radix Ophiopogonis 30g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 15g, Fructus Forsythiae 15g, coptis 9g, Cape jasmine
Sub- 9g, cassia twig 12g, Radix Paeoniae Alba 12g and Radix Glycyrrhizae 6g.
Chinese medicine compound prescription of the present invention on the basis of said components, can also further comprise any one in following raw materials according or several
Kind combination, by weight for:6~15g of Schisandra chinensis, 6~15g of radix scutellariae, 10~30g of corydalis tuber, 2~6g of Radix Notoginseng powder and Radix Codonopsis 12~
30g。
Major function:Chinese medicine compound prescription of the present invention has effects that qi and activate blood circulation removing toxic substances, harmonizing yingfen and weifen;For treating coronary artery more
Unrestrained venereal disease becomes, and improves and delay coronary stenosis disease progression.The coronary artery diffusivity of primary treatment clinically qi deficiency to blood stasis heat toxin syndrome
Lesion and should not row PCI or CABG coronary artery revascularization patient, can allevating angina pectoris symptom, improve patient's myocardial ischemia
It state and improves the quality of living.
Usage and dosage:It is decocted in water for oral dose;Warm water impregnates 30-50 minutes, and water is added not have about 1-2 centimetres of a drug, drug decocting 2 times,
First decocts after boiling about 30 minutes, and second decocts after boiling about 20 minutes, merges the common 400ml of liquid twice, adds in Radix Notoginseng powder, point
It is warmly taken when 1 is small after early, dinner, each 200ml, one dose per day.
The prescription foundation of Chinese medicine compound prescription of the present invention:
Tonifying Qi is the method effected a permanent cure of this disease, promoting blood circulation and removing blood stasis, clearing heat and detoxicating, harmonizing yingfen and weifen treatment worry big method.In coronary disease
During sick disease progression, the local inflammatory response of damaged coronary inner membrance is to induce the startup factor of restenosis, and its pathology
Phlegm-blood stasis knot blocks in the process, and the stasis of blood is changed heat, accumulate in heat toxin, stagnation of blood stasis and heat long, damages train of thought.
Battalion is defended with middle coke is gone out, and it is similar that qi and blood with battalion defends different name.Battalion belongs to cloudy, nutritious and metaplasia blood function;Category sun is defended,
" person that defends gas, so warm boundary between muscles, fills skin, fertile space between skin and muscles, entire person is closed in department." defend gas and there is defence to leak invasion, admittedly take the photograph regulation and control blood, Tianjin
The operation of liquid and defeated cloth, skin nutrition space between skin and muscles regulate and control the effect of thermostasis.Heart governing blood and vessels runs qi and blood, dirty with nutrition whole body
Internal organs, joint, muscle etc., the function and qi and blood of heart are closely related.Heart runing adjustment qi and blood, nutrition whole body;Qi and blood also nutrition
Heart, qi and blood dysfunction cause cardiac function to be damaged, all flourish all damages of the two.With the passing of time worry necessarily causes heart negative and positive of qi and blood to lose
Void causes deficient property disease,《Hardly possible warp》Cloud " damages its heart person, its battalion is adjusted to defend ", this is that the treatment of the treatment deficient property disease of heart is big
Method.This disease state of an illness is complicated, is in a bad way, it is necessary to treat both principal and secondary aspect of disease, detoxify with qi and activate blood circulation, harmonizing yingfen and weifen therapy treats coronary artery
Diffusivity lesion alleviates the progress of coronary stenosis disease.
(One)Prescription analysis:
It is monarch that we, which reuse Radix Astragali,《Book on Chinese herbal medicine is looked for the truth》It says:" Radix Astragali ... for all medicines of tonifying Qi most, to there is the title of over sixty years of age ".This
Place has three using Radix Astragali, purpose:First, Radix Astragali work(mends three cokes and can provide and mend congenital vigour, obstruction of qi in the chest patient's middle age vigour is easily lost.Two
That Radix Astragali can mend pectoral qi, pectoral qi is air in the heart, " pectoral qi product in the heart, for throat, to pass through heart arteries and veins, and go breathing here.”
(《The evil visitor of Ling Shu Miraculous Pivot or Divine Axis》).Third, Radix Astragali specially leads to battalion Wei Zhiqi, the meaning of " damaging its heart person, its battalion is adjusted to defend " is taken.Furthermore " people crosses 40,
Half of YIN QI consumed ", therefore patients with coronary heart disease has the performance of the deficiency of Yin more on the basis of the deficiency of vital energy, it is also related with underlying cause:One merges
It quenches one's thirst, then more deficiency of Yin are scorching;The two " yang-energy person, bothers, and opens ", bothers excessively, liver-kidney irritation, and flaring up of heart fire consumes impairment of yin gas;
Three merges hepatopyretic vertigo (high blood pressure), long consumption impairment of yin liquid.Therefore on the basis of tonifying Qi, clinical practice also adds in nourishing Yin and promoting production of body fluid
Product.Radix Ophiopogonis sweet and slightly bitter taste enters the heart, lung two passes through, sweet Han Zhirun, nourishing heart the moon, relieving restlessness of promoting the production of body fluid tranquilizing the mind, for ministerial drug.
Also product promoting blood circulation and removing blood stasis are mostly used in side, Rhizoma Chuanxiong has the title of " gas medicine in blood ", blood-activating and qi-promoting, analgesic, row the whole body vim and vigour;
The in love product of leech flesh and blood, promoting blood circulation and removing obstruction in channels, Zhu Yu Xiao Disorder;Appropriate Radix Puerariae, heat-clearing except it is dry, promote the production of body fluid to quench thirst;Corydalis tuber blood-activating and qi-promoting
Analgesic;Radix Notoginseng powder is taken after mixing it with water, can stagnation resolvation promoting blood circulation analgesic therapy, there is stagnation resolvation not hinder strong point just.Many blood-activating drugs and the Radix Astragali compatibility of QI invigorating
There are two big benefits:First, the stasis of blood is dispelled, blood work hinders healthy tendency without consuming;Second is that gas blood work certainly enough.Therefore " gas leads to without stagnant, blood work without
The stasis of blood, gas lead to blood work, what, which is suffered from the disease, does not remove ".
Fructus Forsythiae, the coptis, cape jasmine are clearing heat and detoxicating, also to for minister.Fructus Forsythiae bitter is cold in nature, it is main enter the heart channel of Hang-Shaoyin, can removing summer-heat internal heat,
Again can removing summer-heat it is hot and suffocating.The coptis have let out the work(of monarch fire clearly, cape jasmine has the clear fire for rushing down three cokes, the school of heat conduction downlink, such compatibility application
There is the meaning of " huanglian jiedu decoction " in fact, bitter cold is directly rolled over, clearing heat and detoxicating.
Ministerial drug cassia twig, Radix Paeoniae Alba purpose abide by osmanthus, Chinese herbaceous peony in purport Guizhi decoction, and cassia twig is pungent sweet, warm-natured, can help heart-yang, promoting blood circulation;Radix Paeoniae Alba
It is sour, there is the work(that the moon is held back in blood-nourishing, used together with cassia twig, monoyang and monoyin, amount to the work(of harmonizing yingfen and weifen.Radix Glycyrrhizae coordinating the drug actions of a prescription makes for assistant,
And Radix Glycyrrhizae and cassia twig acridness and sweetness activating yang, Radix Glycyrrhizae Radix Paeoniae Alba sour-sweet herbs nourishing yin, help osmanthus spoon harmonizing yingfen and weifen.
The plus-minus application of Chinese medicine compound prescription of the present invention:The plus-minus application of Chinese medicine is Chinese medicine compound prescription energy Mutiple Targets regulation and control body
The practical application basis of pathophysiological process, extends the popularity of compound of Chinese herbal medicine disease and the property taken into account, also adds
The flexibility of compound of Chinese herbal medicine disease.
Optional material composition pharmacological research in prescription
Schisandra chinensis:Schisanhenol has protective effect to isolated rat heart, can protect cardiac structure and function, reduces
Myocardial oxygen consumption extends the holding time for body-centered.Schisandra chinensis lignanoid can inhibit neutrophil infiltration, and it is anti-to reduce inflammatory
Should, so as to mitigate myocardial damage.There is expansion coronary artery and increase coronary flow effect, so as to allevating angina pectoris symptom.
Radix scutellariae:Scutelloside can significantly reduce the malondialdehyde (MDA) of ischemia-reperfusion injury model rat heart muscle
Content, raise tissue in superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activity, carry
Show that scutelloside has the cardiac muscle of reperfusion injury protective effect, mechanism may be anti-with lipid peroxidation caused by antioxidant radical
It should be related.Intracellular Calcium overload is both damage as a result, and causing cell during another aspect ischemical reperfusion injury
The major reason further damaged.It is found in the research of glioma rat model, scutelloside can be substantially reduced by going first
High-calcium ionic concentration level in the neuroglial cytoma of adrenaline (NE) induction, and there are effect doses for the power acted on
Relation.Further research also found, the drop calcium mechanism of scutelloside may be related with reducing the activity of cell membrane phospholipid enzyme C.Right
During rat myocardial ischemia and reperfusion, scutelloside can protect Ischemia Reperfusion by inhibiting cardiac muscle cell apoptosis and inflammatory cell infiltration
Note cardiac muscle.
Corydalis tuber:1. function of resisting myocardial ischemia:The treating myocardial ischemia damage of Induced By Isoprenaline causes lipid with oxygen radical
Peroxidating is related with cytosolic free calcium concentration in cardiomyocyte excess load.Tetrahydropalmatine has stronger inhibition of lipid peroxidation, there is Ca2+Antagonism
Effect.Also play the role of viewpoint think corydalis tuber resist myocardial ischemia damage with its contained by tetrahydropalmatine, dehydrocorydaline, the coptis
Element is related to the direct protective action of cardiac muscle cell with palmatine, and not by anti-oxidative damage mechanism.2. anti thrombotic action:
Tetrahydropalmatine levo form((-)-THP)There is apparent inhibitory action to Rat Experimental cerebral thrombosis, (-)-THP can inhibit
ADP, arachidonic acid and collagen-induced platelet aggregation.In addition, (-)-THP can significantly reduce red blood cell, blood plasma and whole blood
Specific viscosity, hence it is evident that inhibit rats in vitro thrombosis and platelet adhesion reaction, reduce the rat suppository death rate caused by ADP.3.
Improving micro_circulation effect:(-)-THP can reduce erythrocyte aggregation, improve the deformability of red blood cell, so that blood is interior
Frictional force is reduced, and blood viscosity declines, and red blood cell passes through capillary, keeps normal microcirculatory perfusion.Xing Shuhua etc.
Anesthetized dog is injected intravenously with (-)-THP10 mg/kg, as a result observes that dog coronary blood flow increases in 10min after being injected intravenously,
It may be the complex effect to α 1 and alpha-2 receptor retardation that (-)-THP, which improves coronary blood flow effect,.
Radix Notoginseng powder:Radix Notoginseng powder active ingredient Ginsenoside Rg1, can be with the formation of Inhibition test thrombus and thrombin induction
Platelet aggregation, the mechanism of action may with reduce blood platelet Ca2+i it is related.Arasaponin can also raise blood plasma egg
White C activity, and PROTEIN C is a kind of cellulose dependence protein matter synthesized by liver, after being activated in human body, is had anti-
Solidifying activity and rush fibrinolytic, therefore notoginsenoside has apparent anti-freezing, inhibits platelet aggregation, promotes fibrinolysis
Effect, so as to play inhibitory action to patch formation in coronary artery.Ginsenoside Rg1 can promote blood vessel by Fibrinolytic System
Endothelial cell discharge NO and play antithrombotic effect, NO have the function of expand blood vessel, can Green Tea Extract damage, mitigation endothelium it is thin
Fibrinolytic caused by cellular damage is disorderly.NO also has antiplatelet adhesion and aggregation function simultaneously, this is the adherency of blood vessel endothelium antiplatelet
The main reason for.
Radix Codonopsis:Reduce presphygmic period(PEPI)Left room ejection time(LVET)Ratio enhances left heart function, inhibits blood platelet
Adherency and aggregation;Inhibit synthesis of the thromboxane B2 synthesis without influencing 6-Keto-PGF1a.Prompting this product is comparatively ideal prevention
The Chinese medicine of coronary heart disease has certain effect for anginal treatment.
A kind of anginal Chinese medicine compound prescription of coronary artery diffusivity lesion for the treatment of provided by the invention has the beneficial effect that:
1)Solve the problems, such as clinical doctor trained in Western medicine at present to this disease cannot row coronary blood flow Reconstruction it is awkward, solve and be determined for patient
Angina disease, therapy is simple and easy to do, has no adverse reaction, curative for effect, and unique diagnosis and treatment system makes treatment means
Implementation more individuation;
2)Coronary artery diffusivity lesion is treated, angina pectoris symptom and tcm symptom can be obviously improved, improve cardiac ejection
Fraction and electrocardiogram;
3)Improve coronary artery diffusivity lesion patient's myocardial ischemia, improve its heart function and quality of life.
Specific embodiment
Below by clinical testing data and specific embodiment, to further illustrate the present invention the beneficial effect of Chinese medicine compound prescription
Fruit.
Clinical test
First, diagnostic criteria
Western medicine diagnostic criteria is with reference to International Society of Cardiology and association and World Health Organization's clinical name standardization joint
Special topic group is reported《The name of ischemic heart disease and diagnostic criteria》The coronary disease and angina pectoris diagnostic criteria and coronary artery of formulation
CT angiographic results show that coronary artery diffusivity is narrow, are controlled with hypertension, glycosuria patient by drug in normal range (NR).
Syndrome Differentiation of Traditional Chinese Medicine standard reference《New Chinese medicine guideline of clinical investigations》The middle obstruction of qi in the chest (coronary disease and angina pectoris) standard, country
Department of Medical Administration of State Administration of Traditional Chinese Medicines obstruction of qi in the chest acute disease cooperative groups on《Chest impediment and cardialgia(Coronary disease and angina pectoris)Acute disease diagnosis and treatment specification》It is and complete
State's higher institutions of Chinese medicine programming textbook《Chinese Internal Medicine》And the qi deficiency to blood stasis that clinical experience is formulated, heat toxin hinder network Syndrome Diagnostic
Standard, main symptom:Pectoralgia, uncomfortable in chest, palpitaition, shortness of breath.Minor symptom:Lassitude and weak, dry, bitter taste, dysphoria in chestpalms-soles, constipation.Tongue vein:Tongue is purple
It is dark or dark red, thick,yellow and greasy fur, wiry and rolling pulse or sliding number.Possess primary symptom 2, minor symptom 3, with reference to tongue vein.
2nd, case selection and grouping
Meet above-mentioned coronary disease and angina pectoris diagnostic criteria and coronary artery CT angiographic results show coronary artery diffusivity it is narrow and
Syndrome Differentiation of Traditional Chinese Medicine standard person;Age 18-75 Sui;Voluntarily receive the patient of clinical observation and sign informed consent form.
Exclusion criteria:Pectoralgia person caused by excluding acute myocardial infarction and other heart diseases, non-cardiac disease,
It excludes to merge severe hypertension, severe cardiopulmonary insufficiency, severe arrhythmia cordis.
60 are to meet 2 months in October, 2013 in 2012 to include mark in Hospital Attached to Shandong Chinese Medical Univ.'s Cardiological
Accurate patient.Control group and treatment group are divided into using random digits table.Control group 30, wherein male 16, women 14,
Average age (61.67 ± 6.56) year, the course of disease(7.50±6.36)Year;Treatment group 30, wherein male 15, women 15,
Average age(64.00±9.57)Year, the course of disease(8.25±6.71)Year.Two groups of Genders, average age, average course of disease, hearts
Angina Syndrome Scale, coronary artery pathological changes situation etc. compare, no significant difference (P > 0.05).
12 groups of angina pectoris Syndrome Scale distribution situations of table compare
22 groups of patient's coronary artery pathological changes situations of table compare
32 groups of patient's diffusivity lesion vessels distribution situations of table compare
3rd, therapy
Two groups are given diet control, ACEI or ARB, beta-blocker, statins, low molecular weight heparin, low dose
The treatments such as enteric coated aspirin, nitric acid lipid drug.
Control group adds Tongxinluo medicinal capsule on basis of conventional therapy(Shijiazhuang Yi Ling medicine companies pharmaceutcal corporation, Ltd, traditional Chinese medicines are accurate
Word Z19980015), 4, Tid, PO;
Treatment group states the Chinese medicine compound prescription of the present invention for being formulated one in suitable for reading take of basis of conventional therapy, is decocted in water for oral dose, 2 times a day,
Each 200ml.Nitroglycerin can be given during angina pectoris attacks(Beijing Yimin Pharmaceutical Co., Ltd. produces Chinese medicines quasi-word
H11021022), every 0.5mg, sublingual administration.
Formula one:Radix Astragali 45g, Radix Ophiopogonis 30g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 15g, Fructus Forsythiae 15g, coptis 9g, cape jasmine
9g, cassia twig 12g, Radix Paeoniae Alba 12g and Radix Glycyrrhizae 6g.
Two groups of courses for the treatment of are 4 weeks, and during the patient for participating in research treats observation, two groups of cases must not add other treatment again
Western medicine, the Chinese patent drug of coronary disease and angina pectoris.Blood, urine, hepatic and renal function are detected before and after treatment and record adverse events.
4th, research contents and method
(1)Observation index and method
Observe the primary symptoms such as two groups of pretherapy and post-treatment pectoralgias, uncomfortable in chest, palpitaition, shortness of breath and lassitude and weak, dry, bitter taste, five vexed
The variation of the minor symptoms such as heat, constipation, primary symptom by it is light, in, again respectively based on 2,4,6 points, minor symptom by it is light, in, again respectively based on 1,2,3 point,
Tongue vein according to without, have respectively count 0,1 point.The variations such as Ecg ST-T variations and arrhythmia cordis, conventional cardiac ultrasonic measurement
Diastasis left ventricular internal diameter, end-systole Left atrial size, Siopsons methods measurement left ventricular ejection fraction(LVEF).
(2)Efficacy assessment standard:1. angina pectoris symptom curative effect determinate standard, ECG curative effect criterion and tcm syndrome
Curative effect determinate standard:It is write with reference to National Drug Administration's tissue in 2002《New Chinese medicine clinical research guidance is former
Then》;2. Chinese medicine syndrome integral reference《New Chinese medicine guideline of clinical investigations》And make suitably modified, primary symptom:Pectoralgia, it is uncomfortable in chest,
Palpitaition, shortness of breath;Minor symptom:By lassitude and weak, dry, bitter taste, dysphoria in chestpalms-soles, constipation.
(3)Statistical method
Data carry out statistical procedures, measurement data mean ± standard deviation using SPSS18.0 softwares
(x±s)
It represents, is examined using t, enumeration data uses x2It examines, P < 0.05 are statistically significant for difference.
5th, efficacy analysis
(1)The pretherapy and post-treatment angina pectoris symptom curative effect of two groups of patients compares:Effective 22 for the treatment of group(73.3%), effective 8
(26.7%), invalid 0, total effective rate 100%;Effective 10 of control group(33.3%), effective 18(60%), invalid 2
(6.7%), total effective rate 93.3%;Through ridit analytical controls, two groups of angina pectoris symptom curative effect comparing differences are statistically significant(P
< 0.05), treatment group is better than control group.
(2)The comparison of two groups of pretherapy and post-treatment ECG curative effects:Effective 11 for the treatment of group(36.7%), effective 15(50%),
Invalid 4(13.3%), total effective rate 86.7%;Effective 5 of control group(16.7%), effective 7(23.3%), invalid 18
(60%), total effective rate 40%;Through ridit analytical controls, two groups of ECG curative effect comparing differences are statistically significant(P<
0.05), treatment group is better than control group.
(3)The comparison of two groups of pretherapy and post-treatment tcm syndrome comprehensive therapeutic effects:Effective 28 for the treatment of group(93.3%), effective 2
(6.7%), total effective rate 100%;Control group effective 0, effective 30(100%), total effective rate 100%, through ridit analysis inspections
It tests, two groups of tcm syndrome comprehensive therapeutic effect comparing differences are statistically significant(P < 0.01), treatment group is better than control group.
(4)Two groups of pretherapy and post-treatment LVEF and Chinese medicine syndrome integral compare:Left Ventricular Ejection Fraction increases after two groups of treatments, with
Comparing difference is statistically significant before treatment(* P < 0.05);Treatment group's ejection fraction is poor apparently higher than control group after treatment
It is different statistically significant(Δ P < 0.05).Two groups of Chinese medicine syndrome integrals decline after treatment, have system with comparing difference before treatment
Meter learns meaning(* P < 0.05);Treatment group's Chinese medicine syndrome integral is significantly lower than treatment group's group after treatment, and two groups of comparing differences have system
Meter learns meaning(Δ P < 0.05).
4 two groups of pretherapy and post-treatment LVEF of table and Chinese medicine syndrome integral compare
Note:With this group before treatment, * P<0.05;Compared with after control group treatment, Δ P<0.O5.
(5)Two groups of adverse reactions are compared
Adverse reaction is not found in two groups of patient treatment procedures.It is pretherapy and post-treatment two groups of patient's hepatic and renal functions, blood, urine, big
Just it is conventional no abnormal.
The conditions of patients complicated and severe of coronary artery diffusivity lesion, coronary intervention or anesthesia about coronary artery bypass grafting difficulty are big,
Poor prognosis.By above-mentioned statistics as it can be seen that Chinese medicine compound prescription of the present invention can improve coronary artery more by qi and activate blood circulation method of dissipating heat and detoxifying
Unrestrained venereal disease becomes patient's myocardial ischemia, improves its heart function and quality of life.
It chooses model case below and Chinese medicine compound prescription of the present invention is specifically described in optimization formula.
Embodiment 1
It is high certain, man, 56 years old, because of pectoralgia, uncomfortable in chest in local hospital hospitalization, row coronary artery CT showed Coronary Artery in patients within 2010
Diffusivity calcification, the main branch diffusivity of 3 coronary arterys are narrow.Coronary heart disease is diagnosed as, internal medicine conservative treatment gives antiplatelet, expansion hat
Arteries and veins blood vessel adjusts the symptomatic treatments such as blood fat, leaves hospital after improvement.Patient's the past hypertension 8 years, blood pressure 160/90mmHg does not give weight
Depending on.Patient is interrupted oral Betaloc sustained release tablets control heart rate usually, reduces myocardial oxygen consumption, the depressor such as benazepril, Valsartan
Blood pressure is controlled, aspirin antiplatelet to fit adjustable blood fat, delays artery plaque to be in progress.
September is examined for 4 days one within 2012:There is pectoralgia, uncomfortable in chest, shortness of breath because of fatigue recently in patient, and tired postemphasis, breaking-out is earlier above
Frequently, pain is more violent, takes nitroglycerin weak curative effect, with malaise, has palpitation, dizzy, occasionally there is abdominal distension, and dormancy of receiving is poor, no
It easily falls asleep, because waking up with a start, purplish tongue tongue fur is yellow thick, wiry and rolling pulse number.Auxiliary examination:Coronary artery CT shows that coronary artery diffusivity lesion diffuses
Property calcification, 3 coronary stenosis are serious, the narrow > 75% of narrowest position descending anterior branch.Tcm diagnosis:The obstruction of qi in the chest(Deficiency of both qi and yin, stagnant heat are mutual
Knot)Doctor trained in Western medicine diagnoses:1. 2. hypertension of coronary heart disease(2 grades, high danger).
With promoting blood circulation and removing blood stasis in treatment, clearing heat and detoxicating, harmonizing yingfen and weifen is principle, takes two Chinese medicine compound prescription of inventive formulation.
Formula two:Radix Astragali 30g, Radix Ophiopogonis 15g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 30g, Fructus Forsythiae 12g, coptis 12g, cape jasmine
12g, 12 g of cassia twig, 12 g of Radix Paeoniae Alba, Schisandra chinensis 9g, 12 g of radix scutellariae, corydalis tuber 30g, Radix Notoginseng powder 3g and Radix Glycyrrhizae 9g.
It is decocted in water for oral dose, one dose per day, a point morning and evening warmly takes twice, takes 7 days.
September is examined for 11 days two within 2012:Patient's readme pectoralgia, alleviation uncomfortable in chest, pain degree decline, break out 2 times during medication,
Each left and right for 20 seconds, rest can be alleviated.The symptoms such as shortness of breath, weak, dizzy also mitigate, and dormancy of receiving improves, two times can, tongue nature is purple
Dark tongue fur is yellow, deep wiry pulse.Continue to take three Chinese medicine compound prescription of inventive formulation.
Formula three:Radix Astragali 45g, Radix Ophiopogonis 15g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 30g, Fructus Forsythiae 12g, coptis 12g, cape jasmine
9g, cassia twig 15g, 15 g of Radix Paeoniae Alba, Schisandra chinensis 9g, 9 g of radix scutellariae, corydalis tuber 30g, Radix Notoginseng powder 3g, Radix Codonopsis 12g and Radix Glycyrrhizae 9g.
It is decocted in water for oral dose, one dose per day, a point morning and evening warmly takes twice, takes 7 days.
September is examined for 18 days three within 2012:Patient's readme pectoralgia is relieved, and angina pectoris, chest are not caused under general physical exertion
Bored, shortness of breath, weak symptom are clearly better, receive dormancy can, two times tune, the dark tongue of tongue is thin, veins string.Continue to take four Chinese medicine of inventive formulation
Compound.
Formula four:Radix Astragali 30g, Radix Ophiopogonis 15g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 30g, Fructus Forsythiae 12g, coptis 12g, cape jasmine
9g, cassia twig 15g, 15 g of Radix Paeoniae Alba, Schisandra chinensis 6g, corydalis tuber 30g, Radix Notoginseng powder 3g, Radix Codonopsis 12g and Radix Glycyrrhizae 9g.
It is decocted in water for oral dose, one dose per day, a point morning and evening warmly takes twice, and following the service 14 days consolidates curative effect.Effect of follow-up visit by telephone after half a month, situation
Well.
Embodiment 2
Zhang, female, 62 years old, 2006 because pectoralgia, it is uncomfortable in chest in local hospital treat, be diagnosed as coronary heart disease, row coronary artery CT shows,
Coronary artery diffusivity calcification, diffusivity is narrow, LM stenosis > 50%.Patient's hypertension history 10 years, maximal blood pressure 180/
100mmHg, diabetes 3 years.Patient takes orally Betaloc control heart rate, nifedipine, Valsartan control blood pressure, melbine tune usually
Section blood glucose, aspirin platelet aggregation-against, Morbidity control are fine.
September is examined for 27 days one within 2012
There is uncomfortable in chest, pectoralgia without apparent inducement recently in patient, and when rest also may occur in which, dizzy with shortness of breath, weak, even
There is cough, abdominal distension, appetite is fine, sleeps few, easily wakes up with a start, and small, stool is partially dry, the purple dark thin Huang of tongue fur, wiry and frequent pulse.Auxiliary inspection
It looks into:Coronary artery CT shows that coronary artery diffusivity calcified plaque, coronary artery diffusivity is narrow, most narrow place > 70%.Tcm diagnosis:The obstruction of qi in the chest(Gas
Yin bivacuity, stagnation of blood stasis and heat)Doctor trained in Western medicine diagnoses:1. 2. hypertension of coronary heart disease(3 grades, high danger)3. diabetes.
With promoting blood circulation and removing blood stasis in treatment, clearing heat and detoxicating, harmonizing yingfen and weifen is therapy, takes five Chinese medicine compound prescription of inventive formulation.
Formula five:Radix Astragali 30g, Radix Ophiopogonis 15g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 30g, Fructus Forsythiae 12g, coptis 12g, cape jasmine
12g, 12 g of cassia twig, 12 g of Radix Paeoniae Alba, Schisandra chinensis 9g, 12 g of radix scutellariae, corydalis tuber 30g, Radix Notoginseng powder 3g, Radix Codonopsis 12g and Radix Glycyrrhizae 9g.
It is decocted in water for oral dose, one dose per day, a point morning and evening warmly takes twice, takes 7 days.
4 days two October in 2012 examines
Patient's readme is uncomfortable in chest, pectoralgia remission, and sharp ache degree and attack times are reduced, and has palpitation, is shortness of breath, weak
Symptom is obviously improved, receive dormancy can, two times can, purplish tongue thin lingual fur is yellow, veins string.Continue to take six Chinese medicine of inventive formulation and answer
Side.
Formula six:Radix Astragali 30g, Radix Ophiopogonis 15g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 30g, Fructus Forsythiae 12g, coptis 12g, cape jasmine
6g, 15 g of cassia twig, Radix Paeoniae Alba 15g, Schisandra chinensis 9g, 12 g of radix scutellariae, corydalis tuber 30g, Radix Notoginseng powder 3g, Radix Codonopsis 12g and Radix Glycyrrhizae 9g.
It is decocted in water for oral dose, one dose per day, a point morning and evening warmly takes twice, takes 7 days.
11 days three October in 2012 examines
Patient's readme occasionally has uncomfortable in chest, pectoralgia symptom, and angina pectoris is not caused under general activity, and angina pectoris attacks number substantially subtracts
Less and pain degree declines, and has palpitation, and shortness of breath symptom is obviously improved, no dizzy, headache, receive dormancy can, two times tune, the dark tongue of tongue fur is thin
In vain, veins string.Continue to take seven Chinese medicine compound prescription of inventive formulation.
Formula seven:Radix Astragali 30g, Radix Ophiopogonis 15g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 30g, Fructus Forsythiae 12g, coptis 12g, cape jasmine
6g, 15 g of cassia twig, Radix Paeoniae Alba 15g, Schisandra chinensis 9g, 12 g of radix scutellariae, corydalis tuber 30g, Radix Notoginseng powder 3g and Radix Glycyrrhizae 9g.
It is decocted in water for oral dose, one dose per day, a point morning and evening warmly takes twice, and following the service 14 days consolidates curative effect.
Effect of follow-up visit by telephone after half a month, patient's readme state of an illness recover good, satisfactory effect.
More than 2 cases, show that Chinese medicine compound prescription of the present invention can be obviously improved coronary artery diffusivity lesion patient's myocardial ischemia shape
State improves its heart function and quality of life.
Claims (6)
1. a kind of treat the anginal Chinese medicine of coronary artery diffusivity lesion, which is characterized in that is made of, presses the bulk pharmaceutical chemicals of following component
Weight is:15~45g of Radix Astragali, 10~30g of Radix Ophiopogonis, 9~15g of Rhizoma Chuanxiong, 6~9g of leech, 15~30g of Radix Puerariae, 9~18g of Fructus Forsythiae,
9~15g of the coptis, 6~18g of cape jasmine, 6~12g of 9~27g of cassia twig, 9~27g of Radix Paeoniae Alba and Radix Glycyrrhizae.
2. Chinese medicine according to claim 1, which is characterized in that be made of the bulk pharmaceutical chemicals of following component, by weight for:Radix Astragali
45g, Radix Ophiopogonis 30g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 15g, Fructus Forsythiae 15g, coptis 9g, cape jasmine 9g, cassia twig 12g, Radix Paeoniae Alba 12g and
Radix Glycyrrhizae 6g.
3. a kind of treat the anginal Chinese medicine of coronary artery diffusivity lesion, which is characterized in that is formed in bulk pharmaceutical chemicals described in claim 1
On the basis of, further increase following raw material medicaments, by weight for:6~15g of Schisandra chinensis, 6~15g of radix scutellariae, 10~30g of corydalis tuber, Radix Notoginseng
12~30g of 2~6g of powder and Radix Codonopsis.
4. Chinese medicine according to claim 3, which is characterized in that be made of the bulk pharmaceutical chemicals of following component, by weight for:Radix Astragali
45g, Radix Ophiopogonis 15g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 30g, Fructus Forsythiae 12g, coptis 12g, cape jasmine 9g, cassia twig 15g, 15 g of Radix Paeoniae Alba,
Schisandra chinensis 9g, 9 g of radix scutellariae, corydalis tuber 30g, Radix Notoginseng powder 3g, Radix Codonopsis 12g and Radix Glycyrrhizae 9g.
5. Chinese medicine according to claim 3, which is characterized in that be made of the bulk pharmaceutical chemicals of following component, by weight for:Radix Astragali
30g, Radix Ophiopogonis 15g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 30g, Fructus Forsythiae 12g, coptis 12g, cape jasmine 12g, 12 g of cassia twig, Radix Paeoniae Alba 12
G, Schisandra chinensis 9g, 12 g of radix scutellariae, corydalis tuber 30g, Radix Notoginseng powder 3g, Radix Codonopsis 12g and Radix Glycyrrhizae 9g.
6. Chinese medicine according to claim 3, which is characterized in that be made of the bulk pharmaceutical chemicals of following component, by weight for:Radix Astragali
30g, Radix Ophiopogonis 15g, Rhizoma Chuanxiong 15g, leech 6g, Radix Puerariae 30g, Fructus Forsythiae 12g, coptis 12g, cape jasmine 6g, 15 g of cassia twig, Radix Paeoniae Alba 15g,
Schisandra chinensis 9g, 12 g of radix scutellariae, corydalis tuber 30g, Radix Notoginseng powder 3g, Radix Codonopsis 12g and Radix Glycyrrhizae 9g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410360492.5A CN104147346B (en) | 2014-07-28 | 2014-07-28 | It is a kind of to treat the anginal Chinese medicine compound prescription of coronary artery diffusivity lesion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410360492.5A CN104147346B (en) | 2014-07-28 | 2014-07-28 | It is a kind of to treat the anginal Chinese medicine compound prescription of coronary artery diffusivity lesion |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104147346A CN104147346A (en) | 2014-11-19 |
CN104147346B true CN104147346B (en) | 2018-06-05 |
Family
ID=51873110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410360492.5A Active CN104147346B (en) | 2014-07-28 | 2014-07-28 | It is a kind of to treat the anginal Chinese medicine compound prescription of coronary artery diffusivity lesion |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104147346B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105477373B (en) * | 2015-12-29 | 2020-04-24 | 河南中医学院 | Chinese patent medicine for treating myocardial infarction and preparation method thereof |
KR102179234B1 (en) | 2020-07-10 | 2020-11-16 | 박철훈 | Cue support device for billiard with improved grip |
CN113143922B (en) * | 2021-05-07 | 2022-12-20 | 广州医科大学 | Application of DHC in preparation of atherosclerosis treatment preparation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100512852C (en) * | 2007-04-19 | 2009-07-15 | 宋建华 | Composite Chinese medicine took orally for treating coronary heart disease |
CN102327378B (en) * | 2011-09-29 | 2014-07-09 | 广东紫金正天药业有限公司 | Medicinal composition for preventing and treating porcine myocarditis |
-
2014
- 2014-07-28 CN CN201410360492.5A patent/CN104147346B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104147346A (en) | 2014-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104147346B (en) | It is a kind of to treat the anginal Chinese medicine compound prescription of coronary artery diffusivity lesion | |
CN108310199A (en) | A kind of Chinese medicine composition and its preparation for treating coronary disease and angina pectoris | |
CN104758353B (en) | A kind of pharmaceutical composition and its preparation method and application for treating angiocardiopathy | |
CN107007689B (en) | A kind of Chinese medicine preparation of temperature compensation heart kidney and its production and use | |
CN105596777A (en) | Traditional Chinese medicine for dredging blood vessels and reducing blood pressure | |
CN101337017A (en) | Medicine for treating coronary disease | |
CN102343049B (en) | Chinese medicinal capsules for treating hypertension due to liver-yang hyperactivity | |
CN103055122B (en) | The medicine and preparation method thereof of restenosis after prevention percutaneous transluminal coronary stent implantation | |
CN102309561B (en) | Pharmaceutical composition used for preventing and treating urarthritis and hyperuricemia | |
CN102579804B (en) | Chinese medicine for treating stenocardia | |
CN102274357B (en) | Pharmaceutical composition for treating coronary arteriosclerotic heart disease and preparation method thereof | |
CN104258224A (en) | Schisandra chinensis oral solution for treating lung-and-kidney yin-deficiency type chronic bronchitis and preparation method thereof | |
CN103948767A (en) | Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, as well as preparation method and application thereof | |
CN108524740A (en) | A kind of Chinese medicinal formulae for treating rheumatoid arthritis | |
CN109395045A (en) | A kind of clearing away heat and eliminating dampeness tune sugar-pill and preparation method thereof for treating diabetes B MIDDLE ENERGIZER DAMPNESS-HEAT | |
CN104547522B (en) | A kind of Chinese medicine composition for treating arrhythmia cordis and its application | |
CN115177669B (en) | Traditional Chinese medicine composition with efficacy of treating myocardial bridge and application thereof | |
CN102362957B (en) | Chinese prepared medicine for treating deep lupus erythematosus | |
CN106728828A (en) | A kind of Chinese medicine preparation and its preparation technology for treating coronary heart disease | |
CN105943901A (en) | Traditional Chinese medicinal preparation for treating chest congestion after heart bypass | |
CN105412672A (en) | Medicine for treating coronary atherosclerotic cardiopathy and chronic cardiac failure | |
CN105012655A (en) | Traditional Chinese medicinal composition for treating dilated cardiomyopathy and preparation method thereof | |
CN108159214A (en) | It is a kind of to be used to treat Chinese medicine composition of coronary heart disease and preparation method thereof | |
CN105168653A (en) | Traditional Chinese medicine composition used for treating coronary heart disease | |
CN104116794B (en) | A kind of Chinese medicine assisting treatment obesity-related hypertension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |